FDA Inspection 1267654 — CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd.
The FDA completed an inspection of CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd. on Mar 21, 2025 in Shijiazhuang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 21, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shijiazhuang (China)